AMPK: An energy sensor for non-small cell lung cancer progression and treatment
Lung cancer (LC) is the leading cause of cancer-related morbidity and mortality in China, with non-small cell lung cancer (NSCLC) accounting for 85 % of the overall lung cancer cases. AMP-activated protein kinase (AMPK) is a key regulator of energy balance and homeostasis, and its dysregulation is a...
Saved in:
| Main Authors: | Zhi-Ting Zhong, Xu-Yan Wang, Ying Pan, Ke Zhou, Jing-Hui Chen, Yu-Qi Gao, Bo Dai, Zhi-Ling Zhou, Rui-Qi Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825000179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
As a New Tumor Suppressor Gene, PID1 Activates the AMPK-mTOR Signal to Inhibit the Progression of Bladder Cancer
by: Sun L, et al.
Published: (2025-07-01) -
Lactoferrin influences atherosclerotic progression by modulating macrophagic AMPK/mTOR signaling-dependent autophagy
by: Bing Xia, et al.
Published: (2025-03-01) -
Cold plasma promotes Sertoli cell proliferation via AMPK–mTOR signaling pathway
by: Jiao-jiao ZHANG, et al.
Published: (2022-01-01) -
Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management
by: Emily Broberg, et al.
Published: (2025-03-01) -
The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer
by: Gang Wang, et al.
Published: (2020-01-01)